Literature DB >> 24566896

Setting a research agenda for ductal carcinoma in situ that meets the current need for change.

Laura Esserman, Michael Alvarado.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24566896     DOI： 10.7326/M14-0435

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  3 in total

1.  Molecular biology: Marked progress.

Authors:  Hannah Hoag
Journal:  Nature       Date:  2015-11-19       Impact factor: 49.962

2.  MRI ductography of contrast agent distribution and leakage in normal mouse mammary ducts and ducts with in situ cancer.

Authors:  Erica Markiewicz; Xiaobing Fan; Devkumar Mustafi; Marta Zamora; Suzanne D Conzen; Gregory S Karczmar
Journal:  Magn Reson Imaging       Date:  2017-03-30       Impact factor: 2.546

3.  Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?

Authors:  Melissa Pilewskie; Michelle Stempel; Hope Rosenfeld; Anne Eaton; Kimberly J Van Zee; Monica Morrow
Journal:  Ann Surg Oncol       Date:  2016-05-12       Impact factor: 5.344
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.